Oh et al. in 2019 [18], observed that adiponectin increased in individuals with nonalcoholic fatty liver disease subjected to WBV exercise, together with decreases in the TNF-α and CRP levels that could be attributed to the remarkable improvement of hepatic stiffness as a result of the WBV program. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.